Latest Articles and Analysis

Congenital syphilis cases tripled since 2017; integrated response including testing and education needed.

HIV self-tests increase diagnosis but lack linkage to care; community support systems needed.

Payer denial of PrEP disproportionately fails Black women and marginalized communities.

Q4 2023 Watch: Bipartisan PEPFAR reauthorization push; ADAP coverage and Medicaid updates tracked.

HCV vaccine development requires addressing immune variability, access barriers, and community trust.

PDABs and upper-payment limits risk restricting medication access despite affordability intentions.

Research proves alcohol doesn't reduce DAA efficacy for HCV, yet payers continue restricting treatment.

OIG report: 27% of Medicaid HIV enrollees lack evidence of critical services; state disparities exposed.

$100 billion 340B program lacks patient accountability; reform needed for charitable care obligations.

PDAB state implementation variations and how patients can engage in the process.

Opioid settlement funds risk misallocation; MAT gaps for minors and drug court issues identified.

CDC data shows declining health ratings, increased mental health needs, and housing insecurity among PLWH.

Medicaid unwinding: 74% of 5.5M disenrollments due to procedural errors, not ineligibility.

CMS's $9B remedy to hospitals after SCOTUS 340B ruling lacks enforcement of charitable care requirements.

DEA signals openness to telemedicine prescribing of controlled substances, expanding MAT access.

Payers face regulatory scrutiny for systematic coverage denials and prior authorization abuse.

SAMHSA releases Harm Reduction Framework for federal substance use programming and community approaches.

Q3 2023 Watch: HIV disparities coverage; debt ceiling crisis impacts; Medicaid disenrollment trends tracked.

House appropriations proposes deep cuts to HIV/HCV funding including elimination of EHE initiative.

CDC report: HCV persists despite decade-old cure due to payer barriers and screening failures.